Barriers to Transportation: A Study on Patients with End-Stage Renal Disease Receiving in-Center Hemodialysis

被引:1
|
作者
Varghese, Shabu Abraham [1 ]
机构
[1] Univ Cent Florida, Coll Hlth Profess & Sci, Sch Social Work, 12805 Pegasus Dr, Orlando, FL 32816 USA
关键词
barriers to transportation; end-stage renal disease; non-emergency medical transportation; complementary paratransit transportation; CHRONIC KIDNEY-DISEASE; PRACTICE PATTERNS; MORTALITY; HOSPITALIZATION; DIALYSIS; PEOPLE; BURDEN; ESRD;
D O I
10.1080/01488376.2019.1666080
中图分类号
C916 [社会工作、社会管理、社会规划];
学科分类号
1204 ;
摘要
Without kidney transplant, treatment for end-stage renal disease is considered lifelong. Non-emergency medical transportation through Medicaid and the complementary paratransit services under the Americans with Disabilities Act 1990, were identified as the two major sources of transportation services for end-stage renal disease patients. The purpose of the study was to explore barriers to transportation experienced by dialysis patients using transportation services for in-center dialysis and transplant related medical appointments. The study used a non-experimental quantitative research design to explore the barriers and used web-based survey to collect the data. The link to the web-based survey was disseminated on National Kidney Foundation's Facebook and online forum and the survey collected 231 responses. The results of the study indicated prevalence of barriers to transportation for patients with end-stage renal disease. The barriers pose a risk for shortening or missing dialysis appointments affecting dialysis patient's health, leading to an increase in hospitalization and mortality rates. The findings of the study provided foundations for interventions and policy implications to diminish barriers to transportation for patients with end-stage renal disease. Future studies may address barriers to transportation based on end-stage disease patients' physical limitations and at different geographic settings.
引用
收藏
页码:801 / 812
页数:12
相关论文
共 50 条
  • [1] Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis
    Teigen, Mette Maja B.
    Duffull, Stephen
    Dang, Lily
    Johnson, David W.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (11): : 1259 - 1267
  • [2] Survival of patients with AIDS and end-stage renal disease receiving hemodialysis
    Ifudu, O
    Salifu, MO
    Reydel, C
    DiRienzo, R
    McClendon, E
    Bley, A
    Waltrous, C
    Oguagha, C
    Friedman, EA
    [J]. DIALYSIS & TRANSPLANTATION, 2004, 33 (04) : 176 - +
  • [3] Subdural hematoma in patients with end-stage renal disease receiving hemodialysis
    Wang, I. -K.
    Lin, C. -L.
    Wu, Y. -Y.
    Kuo, H. -L.
    Lin, S. -Y.
    Chang, C. -T.
    Yen, T. -H.
    Chuang, F. -R.
    Cheng, Y. -K.
    Huang, C. -C.
    Sung, F. -C.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (06) : 894 - 900
  • [4] In-center nocturnal hemodialysis improves health-related quality of life for patients with end-stage renal disease
    Chance S. Dumaine
    Pietro Ravani
    Manvir K. Parmar
    Kelvin C. W. Leung
    Jennifer M. MacRae
    [J]. Journal of Nephrology, 2022, 35 : 245 - 253
  • [5] In-center nocturnal hemodialysis improves health-related quality of life for patients with end-stage renal disease
    Dumaine, Chance S.
    Ravani, Pietro
    Parmar, Manvir K.
    Leung, Kelvin C. W.
    MacRae, Jennifer M.
    [J]. JOURNAL OF NEPHROLOGY, 2022, 35 (01) : 245 - 253
  • [6] Clinical Oral Findings in Patients With End-stage Renal Disease Receiving Hemodialysis
    Ferreira da Silva, Luiz Carlos
    de Andrade-Junior, Manoel Pacheco
    Piva, Marta Rabello
    Saquete Martins-Filho, Paulo Ricardo
    Freitas, Roseana de Almeida
    [J]. JOURNAL OF CRANIOFACIAL SURGERY, 2015, 26 (03) : 966 - 967
  • [7] Validation of Doripenem Dosing in Patients with End-Stage Renal Disease Receiving Hemodialysis
    Heil, Emily L.
    Daniels, Lindsay M.
    Walko, Christine M.
    Nicolau, David P.
    Smith, Edwin A.
    [J]. ANNALS OF PHARMACOTHERAPY, 2011, 45 (11) : 1455 - 1456
  • [8] Vancomycin assay performance in patients with end-stage renal disease receiving hemodialysis
    Kingery, JR
    Sowinski, KM
    Kraus, MA
    Klaunig, JE
    Mueller, BA
    [J]. PHARMACOTHERAPY, 2000, 20 (06): : 653 - 656
  • [10] SYSTEMATIC REVIEW: HOME VERSUS IN-CENTER HEMODIALYSIS FOR PEOPLE WITH END-STAGE KIDNEY DISEASE
    Palmer, Suetonia
    Tong, Allison
    Manns, Braden
    Craig, Jonathan
    Ruospo, Marinella
    Gargano, Letizia
    Strippoli, Giovanni
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 394 - 394